{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:24Z","timestamp":1786119144687,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/mlr.0b013e3180616c3f","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T18:50:38Z","timestamp":1236192638000},"page":"S16-S22","source":"Crossref","is-referenced-by-count":45,"title":["Creating and Synthesizing Evidence With Decision Makers in Mind"],"prefix":"10.1097","volume":"45","author":[{"given":"David","family":"Atkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210211","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.290.12.1624","article-title":"Practical clinical trials, increasing the value of clinical research for decision making in clinical and health policy.","volume":"290","author":"Tunis","year":"2003","journal-title":"JAMA"},{"key":"R2-6-20210211","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bmj.319.7211.652","article-title":"Can it work? Does it work? Is it worth it.","volume":"319","author":"Haynes","year":"1999","journal-title":"BMJ"},{"key":"R3-6-20210211","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(98)09102-8","article-title":"Can randomized trials inform clinical decisions about individual patients.","volume":"353","author":"Mant","year":"1999","journal-title":"Lancet"},{"issue":"3 Suppl","key":"R4-6-20210211","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process.","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"R5-6-20210211","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomized controlled trials: \u201cTo whom do the results of this trial apply? \u201d","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"R7-6-20210211","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-137-6-200209170-00015","article-title":"Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force.","volume":"137","author":"Nelson","year":"2002","journal-title":"Ann Intern Med"},{"key":"R8-6-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R9-6-20210211","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"R10-6-20210211","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.295.19.2270","article-title":"Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000\u20132005.","volume":"295","author":"Ridker","year":"2006","journal-title":"JAMA"},{"key":"R11-6-20210211","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.0887-378X.2004.00327.x","article-title":"Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages.","volume":"82","author":"Kravitz","year":"2004","journal-title":"Milbank Q"},{"key":"R12-6-20210211","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(05)70240-3","article-title":"Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.","volume":"365","author":"Jackson","year":"2005","journal-title":"Lancet"},{"key":"R13-6-20210211","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/archinte.165.20.2331","article-title":"Implications of pharmacogenomics for drug development and clinical practice.","volume":"165","author":"Ginsburg","year":"2005","journal-title":"Arch Intern Med"},{"key":"R14-6-20210211","doi-asserted-by":"crossref","first-page":"576","DOI":"10.7326\/0003-4819-138-7-200304010-00014","article-title":"Genomics and medicine: distraction, incremental progress, or the dawn of a new age.","volume":"138","author":"Cooper","year":"2003","journal-title":"Ann Intern Med"},{"key":"R15-6-20210211","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(05)17709-5","article-title":"Subgroup analysis in randomized controlled trials: importance, indications, and interpretation.","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"R16-6-20210211","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses.","volume":"116","author":"Oxman","year":"1992","journal-title":"Ann Intern Med"},{"key":"R17-6-20210211","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926","article-title":"Systematic Reviews in Health Care.","author":"Egger","year":"2001"},{"key":"R18-6-20210211","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.STR.0000149621.95215.ea","article-title":"Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.","volume":"36","author":"Leonardi-Bee","year":"2005","journal-title":"Stroke"},{"key":"R19-6-20210211","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/bmj.311.7016.1356","article-title":"An evidence based approach to individualizing treatment.","volume":"311","author":"Glasziou","year":"1995","journal-title":"BMJ"},{"key":"R20-6-20210211","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men.","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"R21-6-20210211","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis.","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"R23-6-20210211","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-130-1-199901050-00004","article-title":"Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention.","volume":"130","author":"Petty","year":"1999","journal-title":"Ann Intern Med"},{"key":"R24-6-20210211","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-2036.2006.03077.x","article-title":"Gastrointestinal bleeding with low-dose aspirin\u2014what's the risk.","volume":"24","author":"Laine","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-6-20210211","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","article-title":"Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease.","volume":"113","author":"Newby","year":"2006","journal-title":"Circulation"},{"key":"R26-6-20210211","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.1995.03520420037035","article-title":"Endarterectomy for asymptomatic carotid artery stenosis.","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R27-6-20210211","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1001\/jama.284.22.2886","article-title":"Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy.","volume":"284","author":"Gross","year":"2000","journal-title":"JAMA"},{"key":"R28-6-20210211","first-page":"CD001923","article-title":"Carotid endarterectomy for asymptomatic carotid stenosis review.","volume":"4","author":"Chambers","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R29-6-20210211","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.279.16.1278","article-title":"Variation in carotid endarterectomy mortality in the Medicare population.","volume":"279","author":"Wennberg","year":"1998","journal-title":"JAMA"},{"key":"R30-6-20210211","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0741-5214(03)00616-5","article-title":"Variation and changes in state-specific carotid endarterectomy and 30-day mortality rates, United States, 1991\u20132000.","volume":"38","author":"Sheikh","year":"2003","journal-title":"J Vasc Surg"},{"key":"R31-6-20210211","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jvs.2003.09.023","article-title":"Multistate improvement in process and outcomes of carotid endarterectomy.","volume":"39","author":"Kresowik","year":"2004","journal-title":"J Vasc Surg"}],"container-title":["Medical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MLR.0b013e3180616c3f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:36:12Z","timestamp":1786037772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005650-200710002-00006"}},"subtitle":["Integrating Evidence From Clinical Trials and Other Study Designs"],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mlr.0b013e3180616c3f","relation":{},"ISSN":["0025-7079"],"issn-type":[{"value":"0025-7079","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}